Difference between revisions of "SKIN5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
<br />
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
Line 17: Line 18:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (KERATINOCYTIC/EPIDERMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Actinic_keratosis|Actinic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Arsenical_keratosis|Arsenical keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:PUVA_keratosis|PUVA keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Squamous_cell_carcinoma_in_situ_(Bowen_disease)|Squamous cell carcinoma in situ (Bowen disease)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_vulgaris|Verruca vulgaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_plantaris_and_palmaris|Verruca plantaris and palmaris]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verruca_plana|Verruca plana]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Solar_lentigo|Solar lentigo]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lichen_planus-like_keratosis|Lichen planus-like keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Clear_cell_acanthoma|Clear cell acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Large_cell_acanthoma|Large cell acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Warty_dyskeratoma|Warty dyskeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Other_benign_keratoses|Other benign keratoses]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinomas|Basal cell carcinomas]]
 +
|Disease (OVERVIEW?)
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_basal_cell_carcinoma|Superficial basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodular_basal_cell_carcinoma|Nodular basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Micronodular_basal_cell_carcinoma|Micronodular basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Infiltrating_basal_cell_carcinoma|Infiltrating basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sclerosing/morphoeic_basal_cell_carcinoma|Sclerosing/morphoeic basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basosquamous_carcinoma|Basosquamous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinoma_with_sarcomatoid_differentiation|Basal cell carcinoma with sarcomatoid differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Basal_cell_carcinoma_with_adnexal_differentiation|Basal cell carcinoma with adnexal differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroepithelial_basal_cell_carcinoma|Fibroepithelial basal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Keratoacanthoma|Keratoacanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Squamous_cell_carcinomas|Squamous cell carcinomas]]
 +
|Disease (OVERVIEW?)
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Verrucous_squamous_cell_carcinoma|Verrucous squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 335:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acantholytic_squamous_cell_carcinoma|Acantholytic squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 346:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 357:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Clear_cell_squamous_cell_carcinoma|Clear cell squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 368:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spindle_cell_squamous_cell_carcinoma|Spindle cell squamous cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 379:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Squamous_cell_carcinoma_with_sarcomatoid_differentiation|Squamous cell carcinoma with sarcomatoid differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 390:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 401:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 3 (MELANOCYTIC TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 432:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Simple_lentigo_and_lentiginous_melanocytic_naevus|Simple lentigo and lentiginous melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 443:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Dysplastic_naevus|Dysplastic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 454:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevus_spilus|Naevus spilus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 465:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Special-site_naevi_(of_the_breast,_axilla,_scalp,_and_ear)|Special-site naevi (of the breast, axilla, scalp, and ear)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 476:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Halo_naevus|Halo naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 487:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Meyerson_naevus|Meyerson naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 498:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Recurrent_naevus|Recurrent naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 509:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Combined_naevus|Combined naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 520:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 531:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Pigmented_epithelioid_melanocytoma|Pigmented epithelioid melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 542:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:BAP1-inactivated_melanocytoma|BAP1-inactivated melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 553:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:MITF_pathway-activated_melanocytic_tumours|MITF pathway-activated melanocytic tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 564:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Low-CSD_melanoma_(including_superficial_spreading_melanoma)|Low-CSD melanoma (including superficial spreading melanoma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 575:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Lentigo_maligna_melanoma|Lentigo maligna melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Desmoplastic_melanoma|Desmoplastic melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 619:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spitz_melanocytoma_(Atypical_Spitz_tumour)|Spitz melanocytoma (Atypical Spitz tumour)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 630:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spitz_melanoma|Spitz melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 641:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acral_naevus|Acral naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 652:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Acral_melanoma|Acral melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 663:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanosis|Melanosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 674:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Genital_naevus|Genital naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 685:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mucosal_melanomas|Mucosal melanomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 696:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevus_of_Ito_and_naevus_of_Ota|Naevus of Ito and naevus of Ota]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 707:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Congenital_dermal_melanocytosis|Congenital dermal melanocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 718:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Blue_naevus|Blue naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 729:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_arising_in_blue_naevus|Melanoma arising in blue naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 740:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Congenital_melanocytic_naevus|Congenital melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 751:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Proliferative_nodules_in_congenital_melanocytic_naevus|Proliferative nodules in congenital melanocytic naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 762:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_arising_in_giant_congenital_naevus|Melanoma arising in giant congenital naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 773:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_naevus|Conjunctival naevus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 784:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 795:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Conjunctival_melanoma|Conjunctival melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 806:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Uveal_melanocytoma|Uveal melanocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 817:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Uveal_melanoma|Uveal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 828:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Diffuse_meningeal_melanocytic_neoplasms:_melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 839:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Circumscribed_meningeal_melanocytic_neoplasms:_melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 850:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Nodular_melanoma|Nodular melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 861:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Naevoid_melanoma|Naevoid melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 872:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Dermal_melanoma|Dermal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 883:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_metastatic_to_the_skin|Melanoma metastatic to the skin]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 894:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Melanoma_metastatic_to_other_organs|Melanoma metastatic to other organs]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 905:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (APPENDAGEAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidrocystoma/cystadenoma|Hidrocystoma/cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 936:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringoma|Syringoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 947:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Poroma|Poroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 958:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringofibroadenoma|Syringofibroadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 969:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidradenoma|Hidradenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 980:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Spiradenoma|Spiradenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 991:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Cylindroma|Cylindroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,002:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Tubular_adenoma|Tubular adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,013:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,024:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mixed_tumour|Mixed tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,035:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Myoepithelioma|Myoepithelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,046:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Adnexal_adenocarcinoma,_NOS|Adnexal adenocarcinoma, NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,057:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,068:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Cribriform_tumour_(previously_carcinoma)|Cribriform tumour (previously carcinoma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,079:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Porocarcinoma|Porocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,090:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:NUT_carcinoma|NUT carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,101:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Malignant_neoplasms_arising_from_spiradenoma,_cylindroma,_or_spiradenocylindroma|Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,112:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Malignant_mixed_tumour|Malignant mixed tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,123:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Hidradenocarcinoma|Hidradenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,134:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,145:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Mucinous_carcinoma|Mucinous carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,156:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Digital_papillary_adenocarcinoma|Digital papillary adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,167:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,178:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Apocrine_carcinoma|Apocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,189:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Squamoid_ductal_eccrine_carcinoma|Squamoid ductal eccrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,200:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Syringocystadenocarcinoma_papilliferum|Syringocystadenocarcinoma papilliferum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,211:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,222:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,233:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Trichoblastoma|Trichoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,244:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[SKIN5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,255:
 
|
 
|
 
|-
 
|-
 +
|[[SKIN5:Melanocytic_matricoma|Melanocytic matricoma]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichilemmoma|Trichilemmoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichoadenoma|Trichoadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichofolliculoma|Trichofolliculoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pilar_sheath_acanthoma|Pilar sheath acanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Tumour_of_the_follicular_infundibulum|Tumour of the follicular infundibulum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichodiscomas_and_fibrofolliculomas|Trichodiscomas and fibrofolliculomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Proliferating_trichilemmal_tumour|Proliferating trichilemmal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pilomatrical_carcinoma|Pilomatrical carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichoblastic_carcinoma/carcinosarcoma|Trichoblastic carcinoma/carcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Trichilemmal_carcinoma|Trichilemmal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceoma|Sebaceoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceous_adenoma|Sebaceous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sebaceous_carcinoma|Sebaceous carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hidradenoma_papilliferum|Hidradenoma papilliferum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroadenoma_and_phyllodes_tumour_of_anogenital_mammary-like_glands|Fibroadenoma and phyllodes tumour of anogenital mammary-like glands]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mammary_Paget_disease|Mammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Adenocarcinoma_of_mammary-gland_type|Adenocarcinoma of mammary-gland type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 5 (TUMOURS OF THE NAIL UNIT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Onychomatricoma|Onychomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Onychopapilloma|Onychopapilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Ungual_fibrokeratoma|Ungual fibrokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Onychocytic_matricoma|Onychocytic matricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Subungual_keratoacathoma|Subungual keratoacathoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 6 (TUMOURS OF HAEMATOPOIETIC AND LYMPHOID ORIGIN)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Mastocytosis|Mastocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mast_cell_sarcoma|Mast cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_involvement_in_myeloid_neoplasms,_including_myeloid_sarcoma|Cutaneous involvement in myeloid neoplasms, including myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mature_plasmacytoid_dendritic_cell_proliferation_associated_with_myeloid_neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Blastic_plasmacytoid_dendritic_cell_neoplasm|Blastic plasmacytoid dendritic cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Xanthelasma|Xanthelasma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reticulohistiocytosis|Reticulohistiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Rosai-Dorfman_Disease|Rosai-Dorfman Disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:ALK_postive_histiocytosis_|ALK postive histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Indeterminate_dendritic_cell_tumour|Indeterminate dendritic cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reactive_B-cell_rich_lymphoid_proliferations|Reactive B-cell rich lymphoid proliferations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_marginal_zone_lymphoma|Primary cutaneous marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_follicle_centre_lymphoma|Primary cutaneous follicle centre lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Secondary_lymphomatoid_granulomatosis_|Secondary lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Reactive_T-cell_rich_lymphoid_proliferations|Reactive T-cell rich lymphoid proliferations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD4-positive_small_or_medium_T-cell_lymphoproliferative_disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Mycosis_fungoides|Mycosis fungoides]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Lymphomatoid_papulosis|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Primary_cutaneous_anaplastic_large_cell_lymphoma|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_gamma/delta_T-cell_lymphoma|Primary cutaneous gamma/delta T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_acral_CD8-positive_T-cell_lymphoproliferative_disorder|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_CD8-positive_aggressive_epidermotropic_cytotoxic_T-cell_lymphoma|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Primary_cutaneous_peripheral_T-cell_lymphoma,_NOS|Primary cutaneous peripheral T-cell lymphoma, NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sezary_syndrome|Sezary syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Severe_mosquito_bite_allergy|Severe mosquito bite allergy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hydroa_vacciniforme_lymphoproliferative_disorder|Hydroa vacciniforme lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Anaplastic_large_cell_lymphoma|Anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodal_T_follicular_helper_lymphoma,_angioimmunoblastic_type|Nodal T follicular helper lymphoma, angioimmunoblastic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:T-cell_prolymphocytic_leukaemia|T-cell prolymphocytic leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Adult_T_cell_leukaemia/lymphoma|Adult T cell leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Inborn_error_of_immunity-associated_lymphoproliferative_disorders|Inborn error of immunity-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (SOFT TISSUE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Naevus_lipomatosus_superficialis|Naevus lipomatosus superficialis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiolipoma|Angiolipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spindle_cell/pleomorphic_lipoma|Spindle cell/pleomorphic lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_lipomatous_tumour|Atypical lipomatous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_liposarcoma|Pleomorphic liposarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sclerotic_fibroma|Sclerotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_fibroma|Pleomorphic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Elastofibroma|Elastofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibrous_papule|Fibrous papule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroblastic_connective_tissue_naevus|Fibroblastic connective tissue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Fibroosseous_tumour_of_digits|Fibroosseous tumour of digits]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatofibroma_(fibrous_histiocytoma)|Dermatofibroma (fibrous histiocytoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_fibromatosis|Superficial fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Inclusion_body_fibromatosis_|Inclusion body fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_acral_fibromyxoma|Superficial acral fibromyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_myxoma_(superficial_angiomyxoma)|Cutaneous myxoma (superficial angiomyxoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatomyofibroma|Dermatomyofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Multinucleate_cell_angiohistiocytoma|Multinucleate cell angiohistiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Plaque-like_CD34+_dermal_fibroma|Plaque-like CD34+ dermal fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EWSR1::SMAD3_rearranged_fibroblastic_tumour|EWSR1::SMAD3 rearranged fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myxofibrosarcoma|Myxofibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cherry_haemangioma|Cherry haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Sinusoidal_haemangioma|Sinusoidal haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Microvenular_haemangioma|Microvenular haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hobnail_haemangioma|Hobnail haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Glomeruloid_haemangioma|Glomeruloid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Papillary_haemangioma|Papillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Spindle_cell_haemangioma|Spindle cell haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Tufted_haemangioma|Tufted haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiokeratoma|Angiokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Congenital_non-progressive_haemangiomas:_rapidly_involuting_congenital_haemangioma_and_non-involuting_congenital_haemangioma|Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Poikilodermatous_plaque-like_haemangioma|Poikilodermatous plaque-like haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Acquired_elastotic_haemangioma|Acquired elastotic haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Verrucous_venous_malformation|Verrucous venous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Arteriovenous_malformation|Arteriovenous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Lymphangioma_(superficial_lymphatic_malformation)|Lymphangioma (superficial lymphatic malformation)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_epithelioid_angiomatous_nodule|Cutaneous epithelioid angiomatous nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Post-radiation_atypical_vascular_lesion|Post-radiation atypical vascular lesion]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hobnail_haemangioendotheliomas|Hobnail haemangioendotheliomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_angiosarcoma|Cutaneous angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Myofibroma_and_myofibromatosis|Myofibroma and myofibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Smooth_muscle_hamartoma|Smooth muscle hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cutaneous_leiomyomas|Cutaneous leiomyomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_intradermal_smooth_muscle_neoplasm|Atypical intradermal smooth muscle neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_hyperneury/Epithelial_sheath_neuroma|Dermal hyperneury/Epithelial sheath neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Hybrid_nerve_sheath_tumours_|Hybrid nerve sheath tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cellular_neurothekeoma|Cellular neurothekeoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_fibrous_histiocytoma|Epithelioid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Non-neural_granular_cell_tumour|Non-neural granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:PEComa_|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Angiomatoid_fibrous_histiocytoma_|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:NTRK-rearranged_spindle_cell_neoplasm|NTRK-rearranged spindle cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Superficial_CD34+_fibroblastic_tumour|Superficial CD34+ fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Pleomorphic_dermal_sarcoma|Pleomorphic dermal sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:CRTC1::TRIM11_cutaneous_tumour|CRTC1::TRIM11 cutaneous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Dermal_clear_cell_sarcoma|Dermal clear cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 8 (METASTASES TO SKIN)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Metastases_to_skin|Metastases to skin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Cancer_of_unknown_primary_site|Cancer of unknown primary site]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH SKIN  MALIGNANCIES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[SKIN5:Familial_melanoma|Familial melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Muir-Torre_syndrome|Muir-Torre syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[SKIN5:Brooke-Spiegler_and_related_syndromes|Brooke-Spiegler and related syndromes]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 16:44, 26 January 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Skin Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (KERATINOCYTIC/EPIDERMAL TUMOURS)
Actinic keratosis Disease
Arsenical keratosis Disease
PUVA keratosis Disease
Squamous cell carcinoma in situ (Bowen disease) Disease
Verruca vulgaris Disease
Verruca plantaris and palmaris Disease
Verruca plana Disease
Seborrhoeic keratosis Disease
Solar lentigo Disease
Lichen planus-like keratosis Disease
Clear cell acanthoma Disease
Large cell acanthoma Disease
Warty dyskeratoma Disease
Other benign keratoses Disease
Basal cell carcinomas Disease (OVERVIEW?)
Superficial basal cell carcinoma Disease
Nodular basal cell carcinoma Disease
Micronodular basal cell carcinoma Disease
Infiltrating basal cell carcinoma Disease
Sclerosing/morphoeic basal cell carcinoma Disease
Basosquamous carcinoma Disease
Basal cell carcinoma with sarcomatoid differentiation Disease
Basal cell carcinoma with adnexal differentiation Disease
Fibroepithelial basal cell carcinoma Disease
Keratoacanthoma Disease
Squamous cell carcinomas Disease (OVERVIEW?)
Verrucous squamous cell carcinoma Disease
Acantholytic squamous cell carcinoma Disease
Lymphoepithelial carcinoma Disease
Clear cell squamous cell carcinoma Disease
Spindle cell squamous cell carcinoma Disease
Squamous cell carcinoma with sarcomatoid differentiation Disease
Merkel cell carcinoma Disease
CHAPTER 3 (MELANOCYTIC TUMOURS)
Junctional, compound, and dermal naevi Disease
Simple lentigo and lentiginous melanocytic naevus Disease
Dysplastic naevus Disease
Naevus spilus Disease
Special-site naevi (of the breast, axilla, scalp, and ear) Disease
Halo naevus Disease
Meyerson naevus Disease
Recurrent naevus Disease
Combined naevus Disease
WNT-activated deep penetrating/plexiform melanocytoma (naevus) Disease
Pigmented epithelioid melanocytoma Disease
BAP1-inactivated melanocytoma Disease
MITF pathway-activated melanocytic tumours Disease
Low-CSD melanoma (including superficial spreading melanoma) Disease
Lentigo maligna melanoma Disease
Desmoplastic melanoma Disease
Pigmented spindle cell naevus (Reed naevus) Disease
Spitz naevus Disease
Spitz melanocytoma (Atypical Spitz tumour) Disease
Spitz melanoma Disease
Acral naevus Disease
Acral melanoma Disease
Melanosis Disease
Genital naevus Disease
Mucosal melanomas Disease
Naevus of Ito and naevus of Ota Disease
Congenital dermal melanocytosis Disease
Blue naevus Disease
Melanoma arising in blue naevus Disease
Congenital melanocytic naevus Disease
Proliferative nodules in congenital melanocytic naevus Disease
Melanoma arising in giant congenital naevus Disease
Conjunctival naevus Disease
Conjunctival melanocytic intraepithelial lesions Disease
Conjunctival melanoma Disease
Uveal melanocytoma Disease
Uveal melanoma Disease
Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma Disease
Nodular melanoma Disease
Naevoid melanoma Disease
Dermal melanoma Disease
Melanoma metastatic to the skin Disease
Melanoma metastatic to other organs Disease
CHAPTER 4 (APPENDAGEAL TUMOURS)
Hidrocystoma/cystadenoma Disease
Syringoma Disease
Poroma Disease
Syringofibroadenoma Disease
Hidradenoma Disease
Spiradenoma Disease
Cylindroma Disease
Tubular adenoma Disease
Syringocystadenoma papilliferum Disease
Mixed tumour Disease
Myoepithelioma Disease
Adnexal adenocarcinoma, NOS Disease
Microcystic adnexal carcinoma Disease
Cribriform tumour (previously carcinoma) Disease
Porocarcinoma Disease
NUT carcinoma Disease
Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma Disease
Malignant mixed tumour Disease
Hidradenocarcinoma Disease
Endocrine mucin-producing sweat gland carcinoma Disease
Mucinous carcinoma Disease
Digital papillary adenocarcinoma Disease
Adenoid cystic carcinoma Disease
Apocrine carcinoma Disease
Squamoid ductal eccrine carcinoma Disease
Syringocystadenocarcinoma papilliferum Disease
Secretory carcinoma Disease
Signet-ring cell/histiocytoid carcinoma Disease
Trichoblastoma Disease
Pilomatricoma Disease
Melanocytic matricoma Disease
Trichilemmoma Disease
Trichoadenoma Disease
Trichofolliculoma Disease
Pilar sheath acanthoma Disease
Tumour of the follicular infundibulum Disease
Trichodiscomas and fibrofolliculomas Disease
Proliferating trichilemmal tumour Disease
Pilomatrical carcinoma Disease
Trichoblastic carcinoma/carcinosarcoma Disease
Trichilemmal carcinoma Disease
Sebaceoma Disease
Sebaceous adenoma Disease
Sebaceous carcinoma Disease
Hidradenoma papilliferum Disease
Fibroadenoma and phyllodes tumour of anogenital mammary-like glands Disease
Mammary Paget disease Disease
Extramammary Paget disease Disease
Adenocarcinoma of mammary-gland type Disease
CHAPTER 5 (TUMOURS OF THE NAIL UNIT)
Onychomatricoma Disease
Onychopapilloma Disease
Ungual fibrokeratoma Disease
Onychocytic matricoma Disease
Subungual keratoacathoma Disease
CHAPTER 6 (TUMOURS OF HAEMATOPOIETIC AND LYMPHOID ORIGIN)
Mastocytosis Disease
Mast cell sarcoma Disease
Cutaneous involvement in myeloid neoplasms, including myeloid sarcoma Disease
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm Disease
Blastic plasmacytoid dendritic cell neoplasm Disease
Langerhans cell histiocytosis Disease
Xanthelasma Disease
Juvenile xanthogranuloma Disease
Reticulohistiocytosis Disease
Rosai-Dorfman Disease Disease
Erdheim-Chester disease Disease
ALK postive histiocytosis Disease
Histiocytic sarcoma Disease
Indeterminate dendritic cell tumour Disease
Reactive B-cell rich lymphoid proliferations Disease
Primary cutaneous marginal zone lymphoma Disease
Primary cutaneous follicle centre lymphoma Disease
Primary cutaneous diffuse large B-cell lymphoma, leg type Disease
Intravascular large B-cell lymphoma Disease
Mantle cell lymphoma Disease
Burkitt lymphoma Disease
Chronic lymphocytic leukaemia/small lymphocytic lymphoma Disease
B-lymphoblastic leukaemia/lymphoma Disease
Secondary lymphomatoid granulomatosis Disease
Reactive T-cell rich lymphoid proliferations Disease
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder Disease
Mycosis fungoides Disease
Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis Disease
Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma Disease
Subcutaneous panniculitis-like T-cell lymphoma Disease
Primary cutaneous gamma/delta T-cell lymphoma Disease
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder Disease
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Disease
Primary cutaneous peripheral T-cell lymphoma, NOS Disease
Sezary syndrome Disease
Severe mosquito bite allergy Disease
Hydroa vacciniforme lymphoproliferative disorder Disease
Anaplastic large cell lymphoma Disease
Nodal T follicular helper lymphoma, angioimmunoblastic type Disease
T-cell prolymphocytic leukaemia Disease
T-lymphoblastic leukaemia/lymphoma Disease
Adult T cell leukaemia/lymphoma Disease
Extranodal NK/T-cell lymphoma Disease
EBV-positive mucocutaneous ulcer Disease
Inborn error of immunity-associated lymphoproliferative disorders Disease
CHAPTER 7 (SOFT TISSUE TUMOURS)
Naevus lipomatosus superficialis Disease
Lipoma Disease
Angiolipoma Disease
Spindle cell/pleomorphic lipoma Disease
Atypical lipomatous tumour Disease
Pleomorphic liposarcoma Disease
Fibroma of tendon sheath Disease
Calcifying aponeurotic fibroma Disease
Sclerotic fibroma Disease
Nuchal-type fibroma Disease
Gardner fibroma Disease
Pleomorphic fibroma Disease
Elastofibroma Disease
Desmoplastic fibroblastoma Disease
Fibrous papule Disease
Fibroblastic connective tissue naevus Disease
Fibroosseous tumour of digits Disease
Dermatofibroma (fibrous histiocytoma) Disease
Superficial fibromatosis Disease
Inclusion body fibromatosis Disease
Plexiform fibrohistiocytic tumour Disease
Superficial acral fibromyxoma Disease
Cutaneous myxoma (superficial angiomyxoma) Disease
Dermatomyofibroma Disease
Multinucleate cell angiohistiocytoma Disease
Plaque-like CD34+ dermal fibroma Disease
Nodular fasciitis Disease
EWSR1::SMAD3 rearranged fibroblastic tumour Disease
Dermatofibrosarcoma protuberans Disease
Myxoinflammatory fibroblastic sarcoma Disease
Myxofibrosarcoma Disease
Cherry haemangioma Disease
Sinusoidal haemangioma Disease
Microvenular haemangioma Disease
Hobnail haemangioma Disease
Glomeruloid haemangioma Disease
Papillary haemangioma Disease
Spindle cell haemangioma Disease
Epithelioid haemangioma Disease
Tufted haemangioma Disease
Angiokeratoma Disease
Infantile haemangioma Disease
Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma Disease
Lobular capillary haemangioma Disease
Poikilodermatous plaque-like haemangioma Disease
Acquired elastotic haemangioma Disease
Verrucous venous malformation Disease
Arteriovenous malformation Disease
Lymphangioma (superficial lymphatic malformation) Disease
Cutaneous epithelioid angiomatous nodule Disease
Post-radiation atypical vascular lesion Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Hobnail haemangioendotheliomas Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Cutaneous angiosarcoma Disease
Glomus tumour Disease
Myopericytoma Disease
Myofibroma and myofibromatosis Disease
Angioleiomyoma Disease
Smooth muscle hamartoma Disease
Cutaneous leiomyomas Disease
EBV-associated smooth muscle tumour Disease
Atypical intradermal smooth muscle neoplasm Disease
Dermal hyperneury/Epithelial sheath neuroma Disease
Solitary circumscribed neuroma Disease
Dermal nerve sheath myxoma Disease
Perineurioma Disease
Neurofibroma Disease
Schwannoma Disease
Granular cell tumour Disease
Hybrid nerve sheath tumours Disease
Malignant peripheral nerve sheath tumour Disease
Cellular neurothekeoma Disease
Epithelioid fibrous histiocytoma Disease
Non-neural granular cell tumour Disease
PEComa Disease
Angiomatoid fibrous histiocytoma Disease
NTRK-rearranged spindle cell neoplasm Disease
Atypical fibroxanthoma Disease
Superficial CD34+ fibroblastic tumour Disease
Pleomorphic dermal sarcoma Disease
Epithelioid sarcoma Disease
CRTC1::TRIM11 cutaneous tumour Disease
Dermal clear cell sarcoma Disease
Ewing sarcoma Disease
CHAPTER 8 (METASTASES TO SKIN)
Metastases to skin Disease
Cancer of unknown primary site Disease
CHAPTER 9 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH SKIN MALIGNANCIES)
Familial melanoma Disease
BAP1 tumour predisposition syndrome Disease
Xeroderma pigmentosum Disease
Naevoid basal cell carcinoma syndrome (Gorlin syndrome) Disease
Carney complex Disease
Muir-Torre syndrome Disease
Brooke-Spiegler and related syndromes Disease
Retrieved from "https://ccga.io/index.php?title=SKIN5:Volunteer_Assignments_and_Opportunities&oldid=14128"